Ephedrine

3produits homologués
1 monographie
Tablet, Capsule

Monographies de Santé Canada

1

Plages de doses approuvées

1
PopulationPlage de dosesFréquence
Adolescents 12 to 17 years and adults 18 years and older8–32 milligramsper day

Mises en garde et contre-indications

8
cautionKeep out of reach of children
cautionConsult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
cautionConsult a health care practitioner/health care provider/health care professional/doctor/physician prior to use, if you are pregnant or breastfeeding (Hackman et al. 2006; Kuczkowski 2006; Mills and Bone 2005; Coffey et al. 2004; Greenway et al. 2004; Haller et al. 2004; Hoffman 2003; Boozer et al. 2002; Boozer et al. 2001; Brinker 2001; Kalman et al. 2000).
cautionConsult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking medication and/or natural health products for allergy symptoms, asthma, cough/cold or weight control (Hackman et al. 2006; Mills and Bone 2005; Naik and Freudenberger 2004; Boozer et al. 2002; Boozer et al. 2001).
cautionConsult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking other products containing caffeine, ephedrine, phenylpropanolamine or pseudoephedrine (Brinker 2018; Hackman et al. 2006; Mills and Bone 2005; Naik and Freudenberger 2004; Boozer et al. 2002; Brinker 2001; Haller and Benowitz 2000; Kalman et al. 2000).
cautionConsult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you have cardiovascular disease, diabetes, difficulty in urination due to prostate enlargement, glaucoma, thyroid problems, seizure disorders or a pre-existing psychiatric condition (Hackman et al. 2006; Mills and Bone 2005; Bensky et al. 2004; Coffey et al. 2004; Greenway et al. 2004; Haller et al. 2004; Hioki et al. 2004; Hoffman 2003; Williamson 2003; Boozer et al. 2002; Boozer et al. 2001; Brinker 2001; Blumenthal et al. 2000; Kalman et al. 2000; BHP 1983).
contraindicationDo not use this product if you are taking, or have taken monoamine oxidase inhibitors in the past two weeks (Brinker 2018; Greenway et al. 2004; Hoffman 2003; Brinker 2001; Blumenthal et al. 2000; Kalman et al. 2000; Dingemanse et al. 1996; Dawson et al. 1995; Elis et al. 1967).
adverse_reactionStop use in case of restlessness, irritability, dizziness, tremor, severe headache, insomnia, loss of appetite, nausea, rapid heartbeat, shortness of breath and/or disturbance of urination (Mills and Bone 2005; Bensky et al. 2004; Mehendale et al. 2004; Shekelle et al. 2003; Boozer et al. 2001; Blumenthal et al. 2000; McGuffin et al. 1997; Astrup et al. 1992).

Noms alternatifs

6
Ephedrine(common)l-Ephedrine(common)(1R,2S)-2-Methylamino-1-phenylpropan-1-ol(alphaR)-alpha-[(1S)-1-(Methylamino)ethyl]-benzenemethanol[R-(R*,S*)]-alpha-[1-(Methylamino)ethyl]-benzenemethanoll-Ephedrine

Quantités courantes dans les produits homologués

1
8 mg3 produits homologués

Vérifiez la conformité de votre produit contenant Ephedrine

Validez votre formulation contre les monographies de Santé Canada et 3 produits homologués contenant Ephedrine.

Analyser gratuitement